These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15099295)

  • 1. Pregnant patients with thrombophilia and subsequent adverse pregnancy outcomes have a decreased first trimester response to thrombomodulin in an activated partial thromboplastin time (APTT) system.
    Paidas MJ; Ku DH; Lee MJ; Lockwood CJ; Arkel YS
    J Thromb Haemost; 2004 May; 2(5):840-1. PubMed ID: 15099295
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of thrombophilia in patients with unexplained recurrent pregnancy loss using a statistical model.
    Wang T; Kang X; He L; Liu Z; Xu H; Zhao A
    Int J Gynaecol Obstet; 2017 Sep; 138(3):283-287. PubMed ID: 28504829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
    Ochshorn Y; Kupferminc MJ; Eldor A; Wolman I; Lessing JB; Yaron Y
    Prenat Diagn; 2001 Aug; 21(8):658-61. PubMed ID: 11536265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester superior sagittal sinus venous thrombosis and antithrombin deficiency.
    McAuley WJ; Hunt BJ; Ahmad HN; Harding K; Nelson-Piercy C
    J Obstet Gynaecol; 2005 Nov; 25(8):808-10. PubMed ID: 16368592
    [No Abstract]   [Full Text] [Related]  

  • 5. Prenatal Screening for Thrombophilias: Indications and Controversies, an Update.
    Louis-Jacques AF; Maggio L; Romero ST
    Clin Lab Med; 2016 Jun; 36(2):421-34. PubMed ID: 27235922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperemesis gravidarum and first trimester sagittal sinus thrombosis.
    Kennelly MM; Baker MR; Birchall D; Hanley JP; Turnbull DM; Loughney AD
    J Obstet Gynaecol; 2008 May; 28(4):453-4. PubMed ID: 18604696
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated first trimester soluble fibrin polymer is associated with adverse pregnancy outcome in thrombophilic patients.
    Paidas MJ; Ku DH; Urban G; Hossain N; Rebarber A; Lockwood CJ; Arkel YS
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):824-6. PubMed ID: 19002052
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombophilia and pregnancy: who should be tested? Which tests should be performed? The biologist point of view].
    Conard J
    Ann Med Interne (Paris); 2003; 154(5-6):340-4. PubMed ID: 15027588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombophilia mimicking necrotizing fasciitis in a pregnant woman.
    Sherley-Dale AC; Rose P; Elliott V; Gach J; Ilchyshyn A
    Clin Exp Dermatol; 2011 Aug; 36(6):693-4. PubMed ID: 21771019
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombophilia and adverse pregnancy outcome.
    Mousa HA; Alfirević Z
    Croat Med J; 2001 Apr; 42(2):135-45. PubMed ID: 11259734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of inherited thrombophilias on first and second trimester maternal serum markers for aneuploidy.
    Derbent AU; Yanik FF; Inegöl Gümüş I; Simavli S; Turhan NÖ
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2177-81. PubMed ID: 22506595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for thrombophilias: indications and controversies.
    Carbone JF; Rampersad R
    Clin Lab Med; 2010 Sep; 30(3):747-60. PubMed ID: 20638586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia and gestational VTE.
    Simioni P
    Thromb Res; 2009; 123 Suppl 2():S41-4. PubMed ID: 19217475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombophilia, anticoagulant therapy and pregnancy].
    Boda Z; László P; Pfliegler G; Tornai I; Rejtö L; Schlammadinger A
    Orv Hetil; 1998 Dec; 139(52):3113-6. PubMed ID: 9914731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The course of pregnancy, delivery and puerperium in a woman with multifactorial thrombophilia--a case report].
    Seremak-Mrozikiewicz A; Drews K; Barlik M
    Ginekol Pol; 2009 Apr; 80(4):299-302. PubMed ID: 19507566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilia and adverse maternal-perinatal outcome: controversies in screening and management.
    Stella CL; How HY; Sibai BM
    Am J Perinatol; 2006 Nov; 23(8):499-506. PubMed ID: 17094039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary thrombophilia and pregnancy: thrombotic risk and pregnancy outcome].
    Fonseca AG
    Acta Med Port; 2012; 25(6):433-41. PubMed ID: 23534596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acquired resistance to activated protein C in pregnancy].
    Schneider DM; von Tempelhoff GF; Hoppenstaedt D; Fareed J; Heilmann L
    Z Geburtshilfe Neonatol; 1998; 202(3):107-10. PubMed ID: 9715525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of antiphospholipid antibodies and factor V (G1691A), prothrombin (G20210A) gene polimorphism among women with pregnancy complications].
    Rajewski M; Skrzypczak J
    Pol Arch Med Wewn; 2006 May; 115(5):417-25. PubMed ID: 17195354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
    Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.